Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuropathic Pain Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Anticonvulsants
1.2.3 Antidepressants
1.2.4 NSAIDs
1.2.5 Opioids
1.2.6 Steroids
1.2.7 Others
1.3 Market by Application
1.3.1 Global Neuropathic Pain Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Diabetic Neuropathy
1.3.3 Chemotherapy-Induced Neuropathy Pain
1.3.4 Postherpetic Neuralgia
1.3.5 Spinal Cord Injury
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuropathic Pain Therapeutics Market Perspective (2018-2033)
2.2 Neuropathic Pain Therapeutics Growth Trends by Region
2.2.1 Global Neuropathic Pain Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Neuropathic Pain Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Neuropathic Pain Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Neuropathic Pain Therapeutics Market Dynamics
2.3.1 Neuropathic Pain Therapeutics Industry Trends
2.3.2 Neuropathic Pain Therapeutics Market Drivers
2.3.3 Neuropathic Pain Therapeutics Market Challenges
2.3.4 Neuropathic Pain Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuropathic Pain Therapeutics Players by Revenue
3.1.1 Global Top Neuropathic Pain Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Neuropathic Pain Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Neuropathic Pain Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuropathic Pain Therapeutics Revenue
3.4 Global Neuropathic Pain Therapeutics Market Concentration Ratio
3.4.1 Global Neuropathic Pain Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuropathic Pain Therapeutics Revenue in 2022
3.5 Neuropathic Pain Therapeutics Key Players Head office and Area Served
3.6 Key Players Neuropathic Pain Therapeutics Product Solution and Service
3.7 Date of Enter into Neuropathic Pain Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuropathic Pain Therapeutics Breakdown Data by Type
4.1 Global Neuropathic Pain Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Neuropathic Pain Therapeutics Forecasted Market Size by Type (2024-2033)
5 Neuropathic Pain Therapeutics Breakdown Data by Application
5.1 Global Neuropathic Pain Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Neuropathic Pain Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Neuropathic Pain Therapeutics Market Size (2018-2033)
6.2 North America Neuropathic Pain Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Neuropathic Pain Therapeutics Market Size by Country (2018-2023)
6.4 North America Neuropathic Pain Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuropathic Pain Therapeutics Market Size (2018-2033)
7.2 Europe Neuropathic Pain Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Neuropathic Pain Therapeutics Market Size by Country (2018-2023)
7.4 Europe Neuropathic Pain Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuropathic Pain Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Neuropathic Pain Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuropathic Pain Therapeutics Market Size (2018-2033)
9.2 Latin America Neuropathic Pain Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Neuropathic Pain Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Neuropathic Pain Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuropathic Pain Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Neuropathic Pain Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Neuropathic Pain Therapeutics Introduction
11.1.4 Pfizer Revenue in Neuropathic Pain Therapeutics Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Detail
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Neuropathic Pain Therapeutics Introduction
11.2.4 Novartis AG Revenue in Neuropathic Pain Therapeutics Business (2018-2023)
11.2.5 Novartis AG Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Neuropathic Pain Therapeutics Introduction
11.3.4 AstraZeneca Revenue in Neuropathic Pain Therapeutics Business (2018-2023)
11.3.5 AstraZeneca Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Neuropathic Pain Therapeutics Introduction
11.4.4 GlaxoSmithKline Revenue in Neuropathic Pain Therapeutics Business (2018-2023)
11.4.5 GlaxoSmithKline Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Detail
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Neuropathic Pain Therapeutics Introduction
11.5.4 Eli Lilly and Company Revenue in Neuropathic Pain Therapeutics Business (2018-2023)
11.5.5 Eli Lilly and Company Recent Development
11.6 Mallinckrodt Pharmaceuticals
11.6.1 Mallinckrodt Pharmaceuticals Company Detail
11.6.2 Mallinckrodt Pharmaceuticals Business Overview
11.6.3 Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Introduction
11.6.4 Mallinckrodt Pharmaceuticals Revenue in Neuropathic Pain Therapeutics Business (2018-2023)
11.6.5 Mallinckrodt Pharmaceuticals Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Neuropathic Pain Therapeutics Introduction
11.7.4 Johnson & Johnson Revenue in Neuropathic Pain Therapeutics Business (2018-2023)
11.7.5 Johnson & Johnson Recent Development
11.8 Abbott
11.8.1 Abbott Company Detail
11.8.2 Abbott Business Overview
11.8.3 Abbott Neuropathic Pain Therapeutics Introduction
11.8.4 Abbott Revenue in Neuropathic Pain Therapeutics Business (2018-2023)
11.8.5 Abbott Recent Development
11.9 Endo Pharmaceuticals, Inc.
11.9.1 Endo Pharmaceuticals, Inc. Company Detail
11.9.2 Endo Pharmaceuticals, Inc. Business Overview
11.9.3 Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Introduction
11.9.4 Endo Pharmaceuticals, Inc. Revenue in Neuropathic Pain Therapeutics Business (2018-2023)
11.9.5 Endo Pharmaceuticals, Inc. Recent Development
11.10 Teva Pharmaceutical Industries Limited
11.10.1 Teva Pharmaceutical Industries Limited Company Detail
11.10.2 Teva Pharmaceutical Industries Limited Business Overview
11.10.3 Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Introduction
11.10.4 Teva Pharmaceutical Industries Limited Revenue in Neuropathic Pain Therapeutics Business (2018-2023)
11.10.5 Teva Pharmaceutical Industries Limited Recent Development
11.11 Merck & Co
11.11.1 Merck & Co Company Detail
11.11.2 Merck & Co Business Overview
11.11.3 Merck & Co Neuropathic Pain Therapeutics Introduction
11.11.4 Merck & Co Revenue in Neuropathic Pain Therapeutics Business (2018-2023)
11.11.5 Merck & Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Neuropathic Pain Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Anticonvulsants
Table 3. Key Players of Antidepressants
Table 4. Key Players of NSAIDs
Table 5. Key Players of Opioids
Table 6. Key Players of Steroids
Table 7. Key Players of Others
Table 8. Global Neuropathic Pain Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Neuropathic Pain Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Neuropathic Pain Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Neuropathic Pain Therapeutics Market Share by Region (2018-2023)
Table 12. Global Neuropathic Pain Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Neuropathic Pain Therapeutics Market Share by Region (2024-2033)
Table 14. Neuropathic Pain Therapeutics Market Trends
Table 15. Neuropathic Pain Therapeutics Market Drivers
Table 16. Neuropathic Pain Therapeutics Market Challenges
Table 17. Neuropathic Pain Therapeutics Market Restraints
Table 18. Global Neuropathic Pain Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Neuropathic Pain Therapeutics Market Share by Players (2018-2023)
Table 20. Global Top Neuropathic Pain Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Pain Therapeutics as of 2022)
Table 21. Ranking of Global Top Neuropathic Pain Therapeutics Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Neuropathic Pain Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Neuropathic Pain Therapeutics Product Solution and Service
Table 25. Date of Enter into Neuropathic Pain Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Neuropathic Pain Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Neuropathic Pain Therapeutics Revenue Market Share by Type (2018-2023)
Table 29. Global Neuropathic Pain Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Neuropathic Pain Therapeutics Revenue Market Share by Type (2024-2033)
Table 31. Global Neuropathic Pain Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Neuropathic Pain Therapeutics Revenue Market Share by Application (2018-2023)
Table 33. Global Neuropathic Pain Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Neuropathic Pain Therapeutics Revenue Market Share by Application (2024-2033)
Table 35. North America Neuropathic Pain Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Neuropathic Pain Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Neuropathic Pain Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Neuropathic Pain Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Neuropathic Pain Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Neuropathic Pain Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Neuropathic Pain Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Neuropathic Pain Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Neuropathic Pain Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Neuropathic Pain Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Neuropathic Pain Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 50. Pfizer Company Detail
Table 51. Pfizer Business Overview
Table 52. Pfizer Neuropathic Pain Therapeutics Product
Table 53. Pfizer Revenue in Neuropathic Pain Therapeutics Business (2018-2023) & (US$ Million)
Table 54. Pfizer Recent Development
Table 55. Novartis AG Company Detail
Table 56. Novartis AG Business Overview
Table 57. Novartis AG Neuropathic Pain Therapeutics Product
Table 58. Novartis AG Revenue in Neuropathic Pain Therapeutics Business (2018-2023) & (US$ Million)
Table 59. Novartis AG Recent Development
Table 60. AstraZeneca Company Detail
Table 61. AstraZeneca Business Overview
Table 62. AstraZeneca Neuropathic Pain Therapeutics Product
Table 63. AstraZeneca Revenue in Neuropathic Pain Therapeutics Business (2018-2023) & (US$ Million)
Table 64. AstraZeneca Recent Development
Table 65. GlaxoSmithKline Company Detail
Table 66. GlaxoSmithKline Business Overview
Table 67. GlaxoSmithKline Neuropathic Pain Therapeutics Product
Table 68. GlaxoSmithKline Revenue in Neuropathic Pain Therapeutics Business (2018-2023) & (US$ Million)
Table 69. GlaxoSmithKline Recent Development
Table 70. Eli Lilly and Company Company Detail
Table 71. Eli Lilly and Company Business Overview
Table 72. Eli Lilly and Company Neuropathic Pain Therapeutics Product
Table 73. Eli Lilly and Company Revenue in Neuropathic Pain Therapeutics Business (2018-2023) & (US$ Million)
Table 74. Eli Lilly and Company Recent Development
Table 75. Mallinckrodt Pharmaceuticals Company Detail
Table 76. Mallinckrodt Pharmaceuticals Business Overview
Table 77. Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Product
Table 78. Mallinckrodt Pharmaceuticals Revenue in Neuropathic Pain Therapeutics Business (2018-2023) & (US$ Million)
Table 79. Mallinckrodt Pharmaceuticals Recent Development
Table 80. Johnson & Johnson Company Detail
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Neuropathic Pain Therapeutics Product
Table 83. Johnson & Johnson Revenue in Neuropathic Pain Therapeutics Business (2018-2023) & (US$ Million)
Table 84. Johnson & Johnson Recent Development
Table 85. Abbott Company Detail
Table 86. Abbott Business Overview
Table 87. Abbott Neuropathic Pain Therapeutics Product
Table 88. Abbott Revenue in Neuropathic Pain Therapeutics Business (2018-2023) & (US$ Million)
Table 89. Abbott Recent Development
Table 90. Endo Pharmaceuticals, Inc. Company Detail
Table 91. Endo Pharmaceuticals, Inc. Business Overview
Table 92. Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Product
Table 93. Endo Pharmaceuticals, Inc. Revenue in Neuropathic Pain Therapeutics Business (2018-2023) & (US$ Million)
Table 94. Endo Pharmaceuticals, Inc. Recent Development
Table 95. Teva Pharmaceutical Industries Limited Company Detail
Table 96. Teva Pharmaceutical Industries Limited Business Overview
Table 97. Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Product
Table 98. Teva Pharmaceutical Industries Limited Revenue in Neuropathic Pain Therapeutics Business (2018-2023) & (US$ Million)
Table 99. Teva Pharmaceutical Industries Limited Recent Development
Table 100. Merck & Co Company Detail
Table 101. Merck & Co Business Overview
Table 102. Merck & Co Neuropathic Pain Therapeutics Product
Table 103. Merck & Co Revenue in Neuropathic Pain Therapeutics Business (2018-2023) & (US$ Million)
Table 104. Merck & Co Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuropathic Pain Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Neuropathic Pain Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Anticonvulsants Features
Figure 4. Antidepressants Features
Figure 5. NSAIDs Features
Figure 6. Opioids Features
Figure 7. Steroids Features
Figure 8. Others Features
Figure 9. Global Neuropathic Pain Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Neuropathic Pain Therapeutics Market Share by Application: 2022 VS 2033
Figure 11. Diabetic Neuropathy Case Studies
Figure 12. Chemotherapy-Induced Neuropathy Pain Case Studies
Figure 13. Postherpetic Neuralgia Case Studies
Figure 14. Spinal Cord Injury Case Studies
Figure 15. Others Case Studies
Figure 16. Neuropathic Pain Therapeutics Report Years Considered
Figure 17. Global Neuropathic Pain Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global Neuropathic Pain Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 19. Global Neuropathic Pain Therapeutics Market Share by Region: 2022 VS 2033
Figure 20. Global Neuropathic Pain Therapeutics Market Share by Players in 2022
Figure 21. Global Top Neuropathic Pain Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Pain Therapeutics as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Neuropathic Pain Therapeutics Revenue in 2022
Figure 23. North America Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America Neuropathic Pain Therapeutics Market Share by Country (2018-2033)
Figure 25. United States Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Neuropathic Pain Therapeutics Market Share by Country (2018-2033)
Figure 29. Germany Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific Neuropathic Pain Therapeutics Market Share by Region (2018-2033)
Figure 37. China Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Japan Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. South Korea Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Southeast Asia Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. India Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Australia Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America Neuropathic Pain Therapeutics Market Share by Country (2018-2033)
Figure 45. Mexico Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Brazil Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa Neuropathic Pain Therapeutics Market Share by Country (2018-2033)
Figure 49. Turkey Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Saudi Arabia Neuropathic Pain Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Pfizer Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2018-2023)
Figure 52. Novartis AG Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2018-2023)
Figure 53. AstraZeneca Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2018-2023)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2018-2023)
Figure 55. Eli Lilly and Company Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2018-2023)
Figure 56. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2018-2023)
Figure 57. Johnson & Johnson Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2018-2023)
Figure 58. Abbott Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2018-2023)
Figure 59. Endo Pharmaceuticals, Inc. Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2018-2023)
Figure 60. Teva Pharmaceutical Industries Limited Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2018-2023)
Figure 61. Merck & Co Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed